BioAtla, Inc.
BCAB- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826892
No open-market purchases or sales by BioAtla, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.22M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding BioAtla, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 65 | 67 | +2 |
| Shares | 17.7M | 24.0M | +6.33M (+35.8%) |
| Value | $31.0M | $14.2M | −$16.9M (−54.3%) |
New holders (21)
Institutions that held BioAtla, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 4,601,066 | $2.72M | 0.34% |
| Acorn Capital Advisors, LLC | 4,032,046 | $2.38M | 1.28% |
| Highbridge Capital Management LLC | 2,509,626 | $1.48M | 0.06% |
| Boxer Capital Management, LLC | 686,347 | $405.8K | 0.03% |
| Jacobs Levy Equity Management, Inc | 648,120 | $383.2K | 0.00% |
| Acadian Asset Management LLC | 158,116 | $92.0K | 0.00% |
| Magnus Financial Group LLC | 47,232 | $27.9K | 0.00% |
| Squarepoint Ops LLC | 46,769 | $27.6K | 0.00% |
| Two Sigma Securities, LLC | 40,074 | $23.7K | 0.00% |
| PVG Asset Management Corp | 36,000 | $21.3K | 0.10% |
| Goldman Sachs Group Inc | 30,343 | $17.9K | 0.00% |
| National Asset Management, Inc. | 30,000 | $17.7K | 0.00% |
| Group One Trading, L.P. | 26,112 | $15.4K | 0.00% |
| Global Wealth Strategies & Associates | 13,769 | $8.14K | 0.00% |
| Engineers Gate Manager LP | 12,820 | $7.58K | 0.00% |
| HRT Financial LP | 12,491 | $7.00K | 0.00% |
| Lazard Asset Management LLC | 4,224 | $2.00K | 0.00% |
| Arcadia Investment Management Corp | 1,403 | $830 | 0.00% |
| R Squared Ltd | 1,240 | $733 | 0.00% |
| BNP Paribas Arbitrage, SA | 858 | $507 | 0.00% |
| SBI Securities Co., Ltd. | 825 | $488 | 0.00% |
Sold out (19)
Institutions that held BioAtla, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Soleus Capital Management, L.P. | 2,517,478 | $4.43M |
| Boxer Capital, LLC | 686,347 | $1.21M |
| Healthcare of Ontario Pension Plan Trust Fund | 512,300 | $901.6K |
| XTX Topco Ltd | 154,967 | $272.7K |
| Diametric Capital, LP | 83,505 | $147.0K |
| SC&H Financial Advisors, Inc. | 65,519 | $115.3K |
| Prelude Capital Management, LLC | 30,410 | $53.5K |
| Cornercap Investment Counsel Inc | 29,805 | $52.5K |
| Qube Research & Technologies Ltd | 29,296 | $51.6K |
| Simplex Trading, LLC | 28,490 | $50.0K |
| Rinkey Investments | 25,310 | $44.5K |
| Chicago Partners Investment Group LLC | 23,217 | $44.1K |
| United Bank | 13,000 | $22.9K |
| Transcend Wealth Collective, LLC | 10,000 | $17.6K |
| Cubist Systematic Strategies, LLC | 7,788 | $13.7K |
| SRS Capital Advisors, Inc. | 1,695 | $2.98K |
| Toth Financial Advisory Corp | 500 | $880 |
| GWM Advisors LLC | 9 | $18 |
| CWM, LLC | 6 | $0 |